Iovance Biotherapeutics, Inc. · NASDAQ:IOVA

Puri Raj K. exercised options for 5,469 Iovance Biotherapeutics, Inc. shares (Form 4)

Traded Jun 1, 2026 · Filed Jun 3, 2026

On Jun 1, 2026, Puri Raj K. (Chief Regulatory Officer) exercised options for 5,469 Iovance Biotherapeutics, Inc. shares, leaving 242,191 shares. Filed Jun 3, 2026 (Form 4).

Options exercised
5,469 shares
Holding after
242,191 shares
Trading plan
No
Role
Chief Regulatory Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 1, 2026Common StockOption exercise5,469244,699Direct
Jun 1, 2026Common StockShares withheld for tax2,508US$3.96242,191Direct

Source

View original at SEC

Related